BLIS Technologies Limited

BLT

NZBLTE0002S8

Pharmaceuticals

End-of-day quote New Zealand S.E. Other stock markets 03:30:00 31/05/2024 am IST			5-day change	1st Jan Change
0.017 ^NZD	-5.56%		-.--%	-10.53%

24/05	BLIS Technologies Limited Provides Earnings Guidance for the Fiscal Year 2025	CI
23/05	Blis Technologies Regains Profitability After Two Years of Losses; Revenue Increases 12% to NZ$11.5 Million	MT

BLIS Technologies Limited Announces Resignation of Colin Dawson from the Board

July 31, 2014 at 09:18 am IST

BLIS Technologies Limited announced that Mr. Colin Dawson has tendered his resignation from the Board of the company with effect from the Annual Meeting.

Latest news about BLIS Technologies Limited

BLIS Technologies Limited Provides Earnings Guidance for the Fiscal Year 2025	24/05	CI
Blis Technologies Regains Profitability After Two Years of Losses; Revenue Increases 12% to NZ$11.5 Million	24/05	MT
BLIS Technologies Limited Reports Earnings Results for the Full Year Ended March 31, 2024	24/05	CI
New Zealand Shares Slide on Tight US Labor Market; Blis Technologies Appoints Sales Agent	17/05	MT
Blis Technologies Appoints Wilson Consumer Products to be Sales Agent	17/05	MT
New Zealand Shares Close Flat on Monday; Blis Technologies Upgrades Fiscal 2024 Guidance	15/04	MT
Blis Technologies Upgrades Fiscal 2024 Guidance	15/04	MT
BLIS Technologies Limited Provides Latest Guidance for the Year Ended 31 March 2024	15/04	CI
Blis Technologies Reports Profitable Third Quarter	23/02	MT
BLIS Technologies Limited Reports Earnings Results for the Half Year Ended September 30, 2023	16/11	CI
BLIS Technologies Limited Reports Earnings Results for the Full Year Ended March 31, 2023	25/23/25	CI
BLIS Technologies Limited Reports Earnings Results for the Half Year Ended September 30, 2022	10/22/10	CI
BLIS Technologies Limited Reports Earnings Results for the Full Year Ended March 31, 2022	31/22/31	CI
Probi AB Completes First Production Batches of Dairy-Free BLIS K12	31/22/31	CI
BLIS Technologies Limited Reports Earnings Results for the Half Year Ended September 30, 2021	18/21/18	CI
Blis Technologies and Probi AB Signs a Licensing and Distribution Agreement	06/21/06	CI
Blis Technologies Limited Reports Earnings Results for the Full Year Ended March 31, 2021	27/21/27	CI
Roolife : Launches Blis Technologies’ Online Store on China’s Tmall Global; Shares Fall 4%	27/21/27	MT
RooLife Group Ltd and Blis Technologies Ltd Launches Flagship Store on China's Tmall Global	27/21/27	CI
Blis Technologies Limited Reports Earnings Results for the Half Year Ended September 30, 2020	19/20/19	CI
Blis Technologies Limited Announces Retirement of Graeme Boyd from the Board	23/20/23	CI
Blis Technologies Limited Reports Earnings Results for the Full Year Ended March 31, 2020	28/20/28	CI
Blis Technologies Launches a New Product UltraBLIS	03/20/03	CI
Blis Technologies Limited Reports Earnings Results for the Half Year Ended September 30, 2019	19/19/19	CI
Blis Technologies Limited Reports Earnings Results for the Full Year Ended March 31, 2019	28/19/28	CI

Chart BLIS Technologies Limited

Duration

Period

More charts

Blis Technologies Limited is a New Zealand-based manufacturer of advanced probiotic strains. The Companyâs principal activity is developing healthcare products based on strains of bacteria that produce bacteriocin activity for sale in New Zealand and overseas. It delivers probiotic solutions for specific health targets, including throat health, halitosis (bad breath), immune support, teeth and gum health and skin health. Its probiotic portfolio includes BLIS K12, BLIS M18 and BLIS Q24. It sells ingredients and finishes goods to manufacturers and wholesale customers. The BLIS K12 (Streptococcus salivarius K12) is a probiotic to support the mouth and throat. The BLIS M18 (Streptococcus salivarius M18) is a probiotic to support teeth and gum health. The BLIS Q24 balances and restores the skin microbiome, restoring its natural health, clarity and radiance. The Companyâs products are sold throughout New Zealand and in Australia, Asia, Europe and the United States.

Sector

Pharmaceuticals

Calendar

14/11/2024 - Q2 2025 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Generic Pharmaceuticals

	1st Jan change	Capi.
BLIS TECHNOLOGIES LIMITED	-10.53%	1.33Cr
SUN PHARMACEUTICAL INDUSTRIES LTD.	+16.12%	4.2TCr
OTSUKA HOLDINGS CO., LTD.	+22.56%	2.23TCr
SANDOZ GROUP AG	+15.78%	1.52TCr
CIPLA LIMITED	+16.46%	1.4TCr
ZYDUS LIFESCIENCES LIMITED	+49.95%	1.21TCr
ONO PHARMACEUTICAL CO., LTD.	-10.77%	679.6Cr
THE MEDICINES COMPANY	-0.05%	678.76Cr
STADA ARZNEIMITTEL	-8.87%	572.55Cr
ASPEN PHARMACARE HOLDINGS LIMITED	+14.18%	549.33Cr